Skip to main content
Top
Published in: International Journal of Hematology 5/2009

01-06-2009 | Original Article

Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery

Authors: Akihiro Sudo, Hideo Wada, Tsutomu Nobori, Norikazu Yamada, Masaaki Ito, Rui Niimi, Masahiro Hasegawa, Koji Suzuki, Atsumasa Uchida

Published in: International Journal of Hematology | Issue 5/2009

Login to get access

Abstract

Soluble fibrin (SF) and D-dimer are considered to be useful for the diagnosis of thrombosis; however, the efficacy of the diagnosis of deep vein thrombosis (DVT) after orthopaedic surgery by SF and D-dimer is still not well established. The present study was designed to evaluate the efficacy of SF and D-dimer in the diagnosis of DVT after orthopaedic surgery. The plasma concentrations of SF and D-dimer were measured in 99 patients following orthopaedic surgery. The plasma concentrations of D-dimer and SF in patients undergoing orthopaedic surgery were markedly high in comparison to healthy volunteers, and these markers were increased after surgery. The plasma concentrations of D-dimer were significantly higher in patients with DVT than in those without DVT at days 4, 7, 10 and 14, and those of SF were significantly higher in patients with DVT than in those without DVT at days 1, 4 and 14. A receiver operating characteristic (ROC) analysis of SF and D-dimer for diagnosis of DVT after surgery generated an ROC curve that showed SF to be better than D-dimer at day 1, while D-dimer was better than SF at day 4. In addition, less than 7.2 μg/ml of D-dimer or 3.6 μg/ml of SF at day 1 after surgery, or less than 7.0 μg/ml of D-dimer at day 4 excluded DVT. These findings suggest that the D-dimer and SF are useful for the diagnosis and exclusion of DVT after orthopaedic surgery.
Literature
7.
go back to reference Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol. 2004;122:178–84. doi:10.1309/X4YN001GU51NGG9Y.PubMedCrossRef Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol. 2004;122:178–84. doi:10.​1309/​X4YN001GU51NGG9Y​.PubMedCrossRef
9.
go back to reference Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagaya S, Mori T, et al. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol. 1995;49:1–5. doi:10.1002/ajh.2830490102.PubMedCrossRef Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagaya S, Mori T, et al. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol. 1995;49:1–5. doi:10.​1002/​ajh.​2830490102.PubMedCrossRef
11.
12.
go back to reference Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.PubMed Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.PubMed
13.
14.
go back to reference Nomura H, Wada H, Mizuno T, Katayama N, Abe Y, Noda M, et al. Negative predictive value of D-dimer for diagnosis of venous thromboembolism. Int J Hematol. 2008;87:250–5.PubMedCrossRef Nomura H, Wada H, Mizuno T, Katayama N, Abe Y, Noda M, et al. Negative predictive value of D-dimer for diagnosis of venous thromboembolism. Int J Hematol. 2008;87:250–5.PubMedCrossRef
15.
go back to reference Nieuwenhuizen W. A reference material for harmonization of D-dimer assays. Thromb Haemost. 1997;77:1031–3.PubMed Nieuwenhuizen W. A reference material for harmonization of D-dimer assays. Thromb Haemost. 1997;77:1031–3.PubMed
16.
go back to reference Dempfle CE, Zips S, Ergül H, Heene DL, the FACT study group. The fibrin assay comparison trial (FACT). Thromb Haemost. 2001;85:671–8.PubMed Dempfle CE, Zips S, Ergül H, Heene DL, the FACT study group. The fibrin assay comparison trial (FACT). Thromb Haemost. 2001;85:671–8.PubMed
17.
go back to reference Brass EP, Forman WB, Edwards RV, Lindan O. Fibrin formation: the role of fibrinogen–fibrin monomer complex. Thromb Haemost. 1976;36:37–48.PubMed Brass EP, Forman WB, Edwards RV, Lindan O. Fibrin formation: the role of fibrinogen–fibrin monomer complex. Thromb Haemost. 1976;36:37–48.PubMed
18.
go back to reference Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost. 2007;5:1438–43. doi:10.1111/j.1538-7836.2007.02571.x.PubMedCrossRef Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost. 2007;5:1438–43. doi:10.​1111/​j.​1538-7836.​2007.​02571.​x.PubMedCrossRef
19.
go back to reference Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia: an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3:2664–70. doi:10.1111/j.1538-7836.2005.01621.x.PubMedCrossRef Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia: an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3:2664–70. doi:10.​1111/​j.​1538-7836.​2005.​01621.​x.PubMedCrossRef
21.
go back to reference Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, et al. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: a randomized, double-blind study. J Thromb Haemost. 2003;1:2119–30. doi:10.1046/j.1538-7836.2003.00368.x.PubMedCrossRef Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, et al. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: a randomized, double-blind study. J Thromb Haemost. 2003;1:2119–30. doi:10.​1046/​j.​1538-7836.​2003.​00368.​x.PubMedCrossRef
22.
go back to reference Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. In: Fibrinogen 4, Current basic and clinical aspects, Matsuda M, Iwanaga S, Takada A, Henschen A, editors. Amsterdam: Excerpta Medica; 1990. pp. 43–8. Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. In: Fibrinogen 4, Current basic and clinical aspects, Matsuda M, Iwanaga S, Takada A, Henschen A, editors. Amsterdam: Excerpta Medica; 1990. pp. 43–8.
23.
go back to reference Soe G, Kohno I, Inuzuka K, Itoh Y, Matsuda M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood. 1996;88:2109–17.PubMed Soe G, Kohno I, Inuzuka K, Itoh Y, Matsuda M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood. 1996;88:2109–17.PubMed
26.
27.
go back to reference Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–40. doi:10.1001/archinte.162.16.1833.PubMedCrossRef Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–40. doi:10.​1001/​archinte.​162.​16.​1833.PubMedCrossRef
Metadata
Title
Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery
Authors
Akihiro Sudo
Hideo Wada
Tsutomu Nobori
Norikazu Yamada
Masaaki Ito
Rui Niimi
Masahiro Hasegawa
Koji Suzuki
Atsumasa Uchida
Publication date
01-06-2009
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0323-4

Other articles of this Issue 5/2009

International Journal of Hematology 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine